0001770069-19-000002.txt : 20190308 0001770069-19-000002.hdr.sgml : 20190308 20190308170933 ACCESSION NUMBER: 0001770069-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190308 DATE AS OF CHANGE: 20190308 EFFECTIVENESS DATE: 20190308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alvarado Therapeutics, Inc. CENTRAL INDEX KEY: 0001770069 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-334440 FILM NUMBER: 19669966 BUSINESS ADDRESS: STREET 1: 75 OXBOW ROAD CITY: CONCORD STATE: MA ZIP: 01742 BUSINESS PHONE: 919-641-8778 MAIL ADDRESS: STREET 1: 75 OXBOW ROAD CITY: CONCORD STATE: MA ZIP: 01742 D 1 primary_doc.xml X0708 D LIVE 0001770069 Alvarado Therapeutics, Inc. NASA Ames Research Center Building 261, Room 141 Moffett Field CA CALIFORNIA 94035 919-641-8778 DELAWARE None None Corporation true 2018 Christopher A Kroeger c/o Alvarado Therapeutics, Inc. NASA Ames Rsrch - Building 261, Room 141 Moffett Field CA CALIFORNIA 94035 Executive Officer Director George Pavlov c/o Alvarado Therapeutics, Inc. NASA Ames Rsrch - Building 261, Room 141 Moffett Field CA CALIFORNIA 94035 Director Robert Malenka c/o Alvarado Therapeutics, Inc. NASA Ames Rsrch - Building 261, Room 141 Moffett Field CA CALIFORNIA 94035 Director Jim Lillie c/o Alvarado Therapeutics, Inc. NASA Ames Rsrch - Building 261, Room 141 Moffett Field CA CALIFORNIA 94035 Executive Officer Peter A Bisgaard c/o Alvarado Therapeutics, Inc. NASA Ames Rsrch - Building 261, Room 141 Moffett Field CA CALIFORNIA 94035 Director Biotechnology Decline to Disclose 06b false 2019-02-22 false true true The underlying shares of common stock issuable upon conversion. false 0 5000000 5000000 0 false 2 0 0 0 false Alvarado Therapeutics, Inc. /s/ Christopher A. Kroeger Christopher A. Kroeger Chief Executive Officer 2019-03-08